Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle

被引:94
作者
Annex, BH
Torgan, CE
Lin, PN
Taylor, DA
Thompson, MA
Peters, KG
Kraus, WE
机构
[1] Vet Affairs Med Ctr, Durham, NC 27710 USA
[2] Duke Univ, Div Cardiol, Durham, NC 27710 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1998年 / 274卷 / 03期
关键词
angiogenesis; growth factor; vascularity; exercise; endurance training;
D O I
10.1152/ajpheart.1998.274.3.H860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) causes endothelial cell proliferation in vitro and angiogenesis in vivo. Glycolytic skeletal muscles have a lower capillary density than oxidative muscles but can increase their capillary density and convert to a more oxidative phenotype when subject to chronic motor nerve stimulation (CMNS). We used Western analysis and immunohistochemical techniques to examine VEGF protein in a rabbit CMNS model of glycolytic skeletal muscle and in muscles with innate glycolytic ver sus oxidative phenotypes. VEGF protein per gram of total protein was increased in stimulated vs. control muscles 2.9 +/- 1.0, 3.6 +/- 1.3, 3.1 +/- 0.5, 4.4 +/- 1.6, and 2.7 +/- 0.3 times after 3 (n = 4), 5 (n = 2), 10 (n = 3), 21 (n = 3), and 56 (n = 2) days, respectively. VEGF protein was increased 3.1 +/- 0.5 times (P < 0.005) before (3, 5, and 10 days) and remained elevated 3.7 +/- 1.0 times (P < 0.05) after (21 and 56 days) the transition to an oxidative phenotype. By immunohistochemistry, VEGF protein was found primarily in the matrix between stimulated muscle fibers but not in the myocytes. In addition, VEGF protein was consistently lower in innate glycolytic compared with oxidative muscles. These findings suggest that VEGF plays a role in the alteration and maintenance of vascular density in mammalian skeletal muscles.
引用
收藏
页码:H860 / H867
页数:8
相关论文
共 30 条
[1]   FAST MYOSIN HEAVY-CHAIN DIVERSITY IN SKELETAL-MUSCLES OF THE RABBIT - HEAVY CHAIN-IID, NOT CHAIN-IIB PREDOMINATES [J].
AIGNER, S ;
GOHLSCH, B ;
HAMALAINEN, N ;
STARON, RS ;
UBER, A ;
WEHRLE, U ;
PETTE, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (1-2) :367-372
[2]   DIFFERENTIAL EXPRESSION OF TISSUE FACTOR PROTEIN IN DIRECTIONAL ATHERECTOMY SPECIMENS FROM PATIENTS WITH STABLE AND UNSTABLE CORONARY SYNDROMES [J].
ANNEX, BH ;
DENNING, SM ;
CHANNON, KM ;
SKETCH, MH ;
STACK, RS ;
MORRISSEY, JH ;
PETERS, KG .
CIRCULATION, 1995, 91 (03) :619-622
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Angiogenic growth factor mRNA responses in muscle to a single bout of exercise [J].
Breen, EC ;
Johnson, EC ;
Wagner, H ;
Tseng, HM ;
Sung, LA ;
Wagner, PD .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (01) :355-361
[5]  
BRONSON DD, 1982, J BIOL CHEM, V257, P3937
[6]   DOMINANT-NEGATIVE AND TARGETED NULL MUTATIONS IN THE ENDOTHELIAL RECEPTOR TYROSINE KINASE, TEK, REVEAL A CRITICAL ROLE IN VASCULOGENESIS OF THE EMBRYO [J].
DUMONT, DJ ;
GRADWOHL, G ;
FONG, GH ;
PURI, MC ;
GERTSENSTEIN, M ;
AUERBACH, A ;
BREITMAN, ML .
GENES & DEVELOPMENT, 1994, 8 (16) :1897-1909
[7]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[8]   VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
FERRARA, N .
TRENDS IN CARDIOVASCULAR MEDICINE, 1993, 3 (06) :244-250
[9]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[10]   VEGF GENE-EXPRESSION IS UP-REGULATED IN ELECTRICALLY STIMULATED RAT SKELETAL-MUSCLE [J].
HANG, J ;
KONG, L ;
GU, JW ;
ADAIR, TH .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (05) :H1827-H1831